GLUE — Monte Rosa Therapeutics Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Monte Rosa Therapeutics Inc (GLUE), worth $10.50M combined. Over the quarter 1 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Duquesne | $7.20M | 0.17% | NEW |
| Renaissance | $2.48M | 0.00% | -73% |
| Persistent | $824.81K | 0.26% | -28.2% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.